Mark A Rademacher

Array ( [id] => 4367831 [patent_doc_number] => 06287859 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Identification, functional expression and chromosal localization of a sustained human proton-gated cation channel' [patent_app_type] => 1 [patent_app_number] => 9/360197 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 34 [patent_no_of_words] => 24214 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287859.pdf [firstpage_image] =>[orig_patent_app_number] => 360197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384854 [patent_doc_number] => 06294658 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Factors involved in gene expression' [patent_app_type] => 1 [patent_app_number] => 9/347833 [patent_app_country] => US [patent_app_date] => 1999-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15944 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294658.pdf [firstpage_image] =>[orig_patent_app_number] => 347833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411654 [patent_doc_number] => 06265546 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Prostate cancer gene' [patent_app_type] => 1 [patent_app_number] => 9/338907 [patent_app_country] => US [patent_app_date] => 1999-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 31 [patent_no_of_words] => 170101 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265546.pdf [firstpage_image] =>[orig_patent_app_number] => 338907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4295219 [patent_doc_number] => 06197749 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes' [patent_app_type] => 1 [patent_app_number] => 9/334647 [patent_app_country] => US [patent_app_date] => 1999-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22263 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197749.pdf [firstpage_image] =>[orig_patent_app_number] => 334647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4303751 [patent_doc_number] => 06251860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Pharmaceutical preparations' [patent_app_type] => 1 [patent_app_number] => 9/299593 [patent_app_country] => US [patent_app_date] => 1999-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6485 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251860.pdf [firstpage_image] =>[orig_patent_app_number] => 299593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4366750 [patent_doc_number] => 06287795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Mch4 and Mch5, apoptotic protease, nucleic acids encoding and methods of use' [patent_app_type] => 1 [patent_app_number] => 9/291692 [patent_app_country] => US [patent_app_date] => 1999-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21617 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287795.pdf [firstpage_image] =>[orig_patent_app_number] => 291692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4382651 [patent_doc_number] => 06303772 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Cyclin D binding factor, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/280590 [patent_app_country] => US [patent_app_date] => 1999-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 40 [patent_no_of_words] => 49328 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303772.pdf [firstpage_image] =>[orig_patent_app_number] => 280590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288006 [patent_doc_number] => 06235477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Human reticulocalbin isoforms' [patent_app_type] => 1 [patent_app_number] => 9/270270 [patent_app_country] => US [patent_app_date] => 1999-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21414 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235477.pdf [firstpage_image] =>[orig_patent_app_number] => 270270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4364584 [patent_doc_number] => 06274339 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity' [patent_app_type] => 1 [patent_app_number] => 9/245041 [patent_app_country] => US [patent_app_date] => 1999-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 173 [patent_figures_cnt] => 180 [patent_no_of_words] => 61623 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274339.pdf [firstpage_image] =>[orig_patent_app_number] => 245041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359894 [patent_doc_number] => 06255282 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Lytic peptides' [patent_app_type] => 1 [patent_app_number] => 9/232153 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 31 [patent_no_of_words] => 9299 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255282.pdf [firstpage_image] =>[orig_patent_app_number] => 232153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4382949 [patent_doc_number] => 06277821 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Therapeutic uses of bactericidal/permeability-increasing protein dimer products' [patent_app_type] => 1 [patent_app_number] => 9/223342 [patent_app_country] => US [patent_app_date] => 1998-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 20771 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277821.pdf [firstpage_image] =>[orig_patent_app_number] => 223342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411592 [patent_doc_number] => 06265541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Uses of .alpha.-conotoxin peptides' [patent_app_type] => 1 [patent_app_number] => 9/219446 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 11032 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265541.pdf [firstpage_image] =>[orig_patent_app_number] => 219446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406108 [patent_doc_number] => 06238888 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Keratinocyte growth factor-2 formulations' [patent_app_type] => 1 [patent_app_number] => 9/218444 [patent_app_country] => US [patent_app_date] => 1998-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 18710 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/238/06238888.pdf [firstpage_image] =>[orig_patent_app_number] => 218444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4364667 [patent_doc_number] => 06274344 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Methods for recombinant microbial production of fusion proteins and BPI-derived peptides' [patent_app_type] => 1 [patent_app_number] => 9/217352 [patent_app_country] => US [patent_app_date] => 1998-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 47191 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274344.pdf [firstpage_image] =>[orig_patent_app_number] => 217352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467902 [patent_doc_number] => 06458942 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => '28-kDa immunoreactive protein gene of Ehrlichia canis and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/201458 [patent_app_country] => US [patent_app_date] => 1998-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15984 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458942.pdf [firstpage_image] =>[orig_patent_app_number] => 09201458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4375797 [patent_doc_number] => 06303332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Corn cDNA encoding southern leaf blight resistance' [patent_app_type] => 1 [patent_app_number] => 9/183959 [patent_app_country] => US [patent_app_date] => 1998-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17600 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303332.pdf [firstpage_image] =>[orig_patent_app_number] => 183959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4256602 [patent_doc_number] => 06204013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'MSP-5 nucleic acid molecules and uses therefor' [patent_app_type] => 1 [patent_app_number] => 9/163285 [patent_app_country] => US [patent_app_date] => 1998-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 31466 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204013.pdf [firstpage_image] =>[orig_patent_app_number] => 163285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4373184 [patent_doc_number] => 06288212 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 9/143124 [patent_app_country] => US [patent_app_date] => 1998-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16350 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288212.pdf [firstpage_image] =>[orig_patent_app_number] => 143124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098587 [patent_doc_number] => 06096864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Peptides for use in wound treatment' [patent_app_type] => 1 [patent_app_number] => 9/007555 [patent_app_country] => US [patent_app_date] => 1998-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2278 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096864.pdf [firstpage_image] =>[orig_patent_app_number] => 007555 [rel_patent_id] =>[rel_patent_doc_number] =>)